A scoping review suggests that certain ADHD medications may help reduce “menopausal brain fog,” with findings based on participants’ self-reported symptoms. The review points to potential benefits for aspects of executive function in perimenopausal and postmenopausal women, including forgetfulness, slower thinking, and difficulty concentrating.
The context is that menopausal brain fog is commonly described during perimenopause and menopause and is thought to relate to hormonal fluctuations affecting brain function. Across outlets, experts emphasize that the research is not yet definitive: the findings have not been published in a peer-reviewed journal, evidence appears stronger for subjective outcomes than for objective cognitive testing, and there are cautions about limited data, potential risks (including cardiovascular effects), and the medications’ lack of FDA approval for this specific use.
Different coverage mainly focuses on what is known versus what is not. Healthline highlights the hypothesis-generating nature of the review and the specific drugs discussed, while MedPage Today leads with the overall possibility that ADHD medications could alleviate symptoms and underscores the need for more studies.
